医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Standards for Forensic Grade Manufacturing Integrated At Promega

2016年09月27日 PM10:00
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

With recent approval in meeting the new ISO 18385 standard, Promega Corporation will be including a “Forensic Grade” classification on products used for human identity by crime labs, government agencies and paternity testing labs worldwide.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160927005209/en/

This logo will appear on products manufactured in alignment with the ISO 18385 standard. (Graphic: B ...

This logo will appear on products manufactured in alignment with the ISO 18385 standard. (Graphic: Business Wire)

The new international standard was published on February 1, 2016. The guideline was developed to “minimize the risk of human DNA contamination in products used to collect, store and analyze biological material for forensic purposes.” These requirements seek to improve the quality of forensic DNA testing by minimizing the risk of human DNA contamination during the manufacturing process.

“ISO 18385 provides guidance to manufacturers on how to minimize the chance of a contamination event and sets pass/fail criteria so that manufacturers can, for the first time, test their products against the requirements of the forensic industry,” stated Dr. Linzi Wilson-Wilde, Director of the National Institute of Forensic Science, Australia/New Zealand and co-author of the Australian Standard upon which the ISO standard is based.

Two Promega scientists, Kristina Pearson, Bulk Production Manager, and Susan Wigdal, Senior Quality Assurance Scientist, were selected by the United States Technical Advisory Group to represent the U.S. on the development of ISO 18385. In addition to Dr. Wilson-Wilde, Promega scientists worked with forensic leaders such as Kermit Channel, the Executive Director of the Arkansas State Crime Laboratory and Chair of the U.S. Technical Advisory Group.

Dr. Channel notes, “Developing a specific ISO standard addressing the manufacturing of products used in forensic DNA laboratories across the globe was critical for our criminal justice stakeholders. We knew that developing this standard was going to be a difficult task requiring the right technical expertise. Fortunately for the U.S., we partnered with exceptional subject matter experts at Promega. The knowledge and expertise that Promega brought to the international table was invaluable in the creation of this ISO document that now provides DNA laboratories across the globe confidence in the products we use.”

For more information about ISO 18385 and Promega’s efforts related to the standard, please visit: http://www.promega.com/ForensicGradeFAQ/

Promega first certified to international standards for quality management systems in 1998, and its commitment continues with our current ISO certifications. The ISO series of quality management system standards are developed and maintained by the International Organization for Standardization.

About Promega

Promega Corporation has provided products for DNA-based human identification for more than 25 years. Promega is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 3,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160927005209/en/

CONTACT

Promega Corporation
Penny Patterson
Sr. Director,
Communications
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Capability Counts 2017 Conference将于2017年5月在华盛顿特区举行,NASA人类探索和操作任务理事会的Greg Williams将发表主题演讲
  • Herbalife Ltd. Reaches Agreement in Principle to Form Joint Venture with China’s Tasly Holding Group
  • Origin, Arcadia Announce China Biotechnology Collaboration in Corn
  • Truxima™, the first biosimilar mAb in oncology, granted EU marketing authorisation
  • レマン・マイクロ・デバイセズのスマートフォン組み込み型ヘルスモニタリングシステムは世界で初めて医学的に正確な測定が可能となり、FDA承認の取得に向け準備完了